메뉴 건너뛰기




Volumn 20, Issue 6, 2001, Pages 687-688

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial

(1)  Pereira, H a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; RETEPLASE;

EID: 0034876186     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note
Times cited : (5)

References (8)
  • 2
    • 0035927988 scopus 로고    scopus 로고
    • Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization
    • (2001) N Engl J Med , vol.344 , pp. 1888-1894
    • Topol, E.J.1    Moliterno, D.J.2    Herrmann, H.C.3
  • 4
    • 0035897893 scopus 로고    scopus 로고
    • Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: The GUSTO IV-ACS randomized trial
    • (2001) Lancet , vol.357 , pp. 1915-1924
  • 5
    • 0035897888 scopus 로고    scopus 로고
    • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
    • (2001) Lancet , vol.357 , pp. 1905-1914
  • 7
    • 0343798542 scopus 로고    scopus 로고
    • Trial of abciximab with and without low-dose reteplase for acute myocardial infarction
    • (2000) Circulation , vol.101 , pp. 2788-2794


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.